Effect of secretory DKK3 on circulating CD56 bright natural killer cells in patients with liver cancer.
Da-Hua LiuGui-Min WenChang-Liang SongPu XiaPublished in: The International journal of biological markers (2023)
Improving the clinical efficacy of NK cells through DKK3 will become a new strategy for cancer immunotherapy.
Keyphrases